CVS Health Corporation (ETR:CVS)
Germany · Delayed Price · Currency is EUR | Market Cap | 85.00B |
| Revenue (ttm) | 327.26B |
| Net Income (ttm) | 3.86B |
| Shares Out | n/a |
| EPS (ttm) | 3.06 |
| PE Ratio | 22.03 |
| Forward PE | 11.62 |
| Dividend | 2.40 (3.58%) |
| Ex-Dividend Date | Jul 22, 2025 |
| Volume | 217 |
| Average Volume | 263 |
| Open | 67.17 |
| Previous Close | 66.65 |
| Day's Range | 66.95 - 67.97 |
| 52-Week Range | 41.68 - 67.97 |
| Beta | n/a |
| RSI | 64.73 |
| Earnings Date | Oct 29, 2025 |
About CVS Health
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs and Medicaid health care management services. It serves employer groups, individuals, coll... [Read more]
Financial Performance
In 2024, CVS Health's revenue was $370.66 billion, an increase of 3.93% compared to the previous year's $356.62 billion. Earnings were $4.61 billion, a decrease of -44.70%.
Financial numbers in USD Financial StatementsNews
Deal Dispatch: Confluent Considers Sale, Rothschild Exits The Economist, CVS Feels The Pain
New On The Block Confluent Inc. (NASDAQ: CFLT), a California-based data streaming company, is exploring a potential sale after drawing interest from several private equity firms and tech companies. A...
CVS Health, Clover update on Medicare Star Ratings for 2026
CVS Health’s (CVS) stock and Clover Health (CLOV) stock are in focus as the CMS announced Medicare Star Ratings for 2026. Read more here.
CVS says over 81% of members are in high-rated Medicare Advantage plans for 2026
CVS Health said on Thursday that its Aetna insurance business has over 81% of members in Medicare Advantage plans that are rated 4 stars or higher for 2026.
Aetna achieves over 81% of Medicare Advantage members in 4-Star plans and over 63% in 4.5-Star plans for 2026
HARTFORD, Conn., Oct. 9, 2025 /PRNewswire/ -- Aetna®, a CVS Health® company (NYSE: CVS), announced today that over 81 percent of its Medicare Advantage (MA) members are in 2026 Medicare Advantage Pres...
CVS Stock Rating Maintained with Raised Price Target by Mizuho | CVS Stock News
CVS Stock Rating Maintained with Raised Price Target by Mizuho | CVS Stock News
CVS Health (CVS) Is Considered a Good Investment by Brokers: Is That True?
According to the average brokerage recommendation (ABR), one should invest in CVS Health (CVS). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recom...
Wells Fargo Raises Price Target for CVS Health | CVS Stock News
Wells Fargo Raises Price Target for CVS Health | CVS Stock News
CVS Health opens new Workforce Innovation and Talent Center in Fort Worth
In collaboration with Fort Worth Housing Solutions, the center offers no-cost training for Fort Worth's future health care workforce FORT WORTH, Texas , Oct. 7, 2025 /PRNewswire/ -- CVS Health® (NYSE:...
Peering Into CVS Health Corp's Recent Short Interest
CVS Health Corp's (NYSE: CVS) short interest as a percent of float has risen 25.33% since its last report. According to exchange reported data, there are now 23.62 million shares sold short , which i...
Company Diary: Imperial Brands, CVS
Imperial Brands and CVS are amongst the FTSE 350 and other companies reporting earnings for the week of 06 October
Notable Wednesday Option Activity: CVS, HOOD, REGN
Looking at options trading activity among components of the S&P 500 index, there is noteworthy activity today in CVS Health Corporation (Symbol: CVS), where a total volume of 38,300 contracts has been...
CVS (CVS) Pushes for Lower Copay on Novo Nordisk's Wegovy
CVS (CVS) Pushes for Lower Copay on Novo Nordisk's Wegovy
UnitedHealth, CVS Health, Humana scale back Medicare Advantage offerings
YieldBoost CVS Health From 3.5% To 6.4% Using Options
Shareholders of CVS Health Corporation (Symbol: CVS) looking to boost their income beyond the stock's 3.5% annualized dividend yield can sell the January 2028 covered call at the $105 strike and colle...
Pfizer's TrumpRx Pact Sends Shockwaves: Why UnitedHealth, Lilly And CVS Can't Look Away
Pfizer Inc's (NYSE:PFE) deal with Washington isn't just a handshake in the Oval Office — it's a seismic jolt to America's drug-pricing game. By agreeing to sell medicines on the government's new Trump...
CVS Health to offer 2026 Medicare prescription drug plans in 43 states
CVS Health said on Wednesday its health insurance unit will offer medicare advantage prescription drug plans in 43 states and Washington D.C. for 2026.
Aetna 2026 Medicare Advantage plans deliver access to affordable, personalized care
Providing access to affordable care $0 copays on Tier 1 drugs & covered vaccines at in-network pharmacies1, $0 copay for colonoscopies and mammograms at in-network providers $0 copay for annual Health...
BetterInvesting™ Magazine Update on Vertiv Holdings Co. (NYSE: VRT) and CVS Health Corp. (NYSE: CVS)
TROY, Mich. , Sept. 30, 2025 /PRNewswire/ -- Vertiv Holdings Co.'s recent report has investors wondering if the company's stock is fairly valued. Or is it in the buy range? As such, the Editorial Advi...
BetterInvesting™ Magazine Update on Vertiv Holdings Co. (NYSE: VRT) and CVS Health Corp. (NYSE: CVS)
TROY, Mich. , Sept. 30, 2025 /PRNewswire/ -- Vertiv Holdings Co.'s recent report has investors wondering if the company's stock is fairly valued.
CVS Health to hold third quarter 2025 earnings conference call
WOONSOCKET, R.I. , Sept. 30, 2025 /PRNewswire/ -- CVS Health® (NYSE: CVS) will hold a conference call with analysts and investors on Wednesday, October 29 th, 2025, at 8:00 a.m.
Validea Detailed Fundamental Analysis - CVS
Below is Validea's guru fundamental report for CVS HEALTH CORP (CVS). Of the 22 guru strategies we follow, CVS rates highest using our Multi-Factor Investor model based on the published strategy of Pi...
Guru Fundamental Report for CVS
Below is Validea's guru fundamental report for CVS HEALTH CORP (CVS). Of the 22 guru strategies we follow, CVS rates highest using our Multi-Factor Investor model based on the published strategy of Pi...
CVS Health (CVS) Among PBMs Proposing Voluntary Changes to Avoid Regulation
CVS Health (CVS) Among PBMs Proposing Voluntary Changes to Avoid Regulation
Investors Heavily Search CVS Health Corporation (CVS): Here is What You Need to Know
CVS Health (CVS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
CVS Health: A Deeply Undervalued Giant Investors Keep Ignoring
CVS Health remains a solid, undervalued business, despite recent underperformance, versus the S&P 500 and ongoing margin pressures. Q2/25 results showed strong revenue growth but declining operating i...